Ciclopirox topical - Acrux

Drug Profile

Ciclopirox topical - Acrux

Alternative Names: Ciclopirox MDTS

Latest Information Update: 18 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Acrux
  • Class Antifungals; Pyridones; Small molecules
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Onychomycosis

Most Recent Events

  • 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including onychomycosis
  • 23 May 2005 Preclinical trials in Onychomycosis in USA (Topical)
  • 12 Jul 2004 Ciclopirox topical is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top